MGX Platform (Nuclease)

About Metagenomi

Metagenomi is a clinical-stage biotechnology company leveraging its proprietary metagenomics discovery platform to unearth novel genome editing systems from nature's microbial diversity. The company has built a massive proprietary database and uses AI-enabled screening to identify and engineer compact, efficient editors, advancing a pipeline of in vivo genetic medicines. Its strategy focuses on high-value programs in diseases with clear biology and regulatory paths, while also pursuing platform partnerships to expand the reach of its technology.

Therapeutic Areas

Other Undisclosed CNS Target Drugs